Cross-category comparison
Orlistat vs Structured Lifestyle
Different categories, normalised only where comparison is meaningful.
Orlistat
Typically produces more modest average loss than GLP-1/GIP medicines; individual response varies
Structured lifestyle programme
Moderate on average, highly variable
How to use this comparison
Compare the factual differences below. We do not assign numerical treatment rankings: outcomes depend on the specific treatment, population, follow-up and your clinical circumstances.
Category-specific detail
| Issue | Orlistat | Structured lifestyle programme |
|---|---|---|
| Appetite support | Not covered in this row | Does not directly pharmacologically suppress appetite |
| Approach | Not covered in this row | Nutrition + physical activity + behavioural support |
| Cost | Not covered in this row | Can be low |
| Evidence anchor | Typically produces more modest average loss than GLP-1/GIP medicines; individual response varies | Not covered in this row |
| How it works | Gastrointestinal lipase inhibitor | Not covered in this row |
| How taken | Capsule with meals — Up to three times daily with fat-containing meals | Not covered in this row |
| Main trade-offs | Lower average efficacy; Oily stools/urgency and other GI effects can be disruptive; Must be taken around fat-containing meals; Fat-soluble vitamin considerations | Not covered in this row |
| Maintenance | Can be continued where effective/tolerated; diet composition affects tolerability | Skills can be maintained indefinitely; relapse plan still needed |
| Medical intensity | Not covered in this row | Low |
| Muscle support | Not covered in this row | Strength training + adequate protein can actively support lean mass |
| NHS context | Long-established NHS option; prescribing criteria and local practice apply | Not covered in this row |
| Speed | Not covered in this row | Gradual |
| UK licence | UK weight management licence | Not covered in this row |
| Weight-loss potential | Not covered in this row | Moderate on average, highly variable |
A detail omitted from one column is not evidence that it is irrelevant to that treatment. Use the full guides and discuss clinical suitability with your treating team.
Want support putting this into practice?
The Shift Programme is being built to combine evidence-led education, decision support, practical tools, progress tracking and long-term maintenance.
Sources & evidence
Check the underlying guidance directly: